Bienvenu J, Coulon L, Barbier Y, Barbier M, Doche C, Lepape A, Guenounou M
Laboratoire d'Immunologie et de Biologie de l'Inflammation, Pierre Bénite, France.
Nouv Rev Fr Hematol (1978). 1992;34 Suppl:S65-7.
The aim of this work is to reinvestigate the pentoxifylline (PTX) action on TNF alpha and IL-6 production using a whole blood ex-vivo model. 5 healthy controls, 2 septic patients (4 samples) and 3 patients in septic shock (7 samples) have been studied. Our data confirm the inhibitory action of PTX on TNF alpha production in healthy controls. This inhibition is nearly complete for a PTX concentration of 10(-3) M. More surprisingly a suppressive activity of PTX on IL-6 secretion has been found both in controls and septic patients. On the 7 samples of the 3 patients with septic shock no TNF alpha production has been detected. Taken altogether, these observations suggest a potential role for PTX as a modulator of the major cytokines involved in the pathogenesis of septic shock.
这项工作的目的是使用全血体外模型重新研究己酮可可碱(PTX)对肿瘤坏死因子α(TNFα)和白细胞介素-6(IL-6)产生的作用。研究了5名健康对照者、2名脓毒症患者(4份样本)和3名脓毒症休克患者(7份样本)。我们的数据证实了PTX对健康对照者TNFα产生的抑制作用。对于10^(-3) M的PTX浓度,这种抑制几乎是完全的。更令人惊讶的是,在对照者和脓毒症患者中均发现PTX对IL-6分泌具有抑制活性。在3名脓毒症休克患者的7份样本中未检测到TNFα的产生。综上所述,这些观察结果表明PTX作为参与脓毒症休克发病机制的主要细胞因子的调节剂具有潜在作用。